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Abstract 
Background and Objective: Though devices for hair growth based on low levels of light 
have shown encouraging results, further improvements of their efficacy is impeded by a lack 
of knowledge on the exact molecular targets that mediate physiological response in skin and 
hair follicle. The aim of this study was to investigate the expression of selected light-sensitive 
receptors in the human hair follicle and to study the impact of UV-free blue light on hair 
growth ex vivo. 
Material and Methods: The expression of Opsin receptors in human skin and hair follicles 
has been characterised using RT-qPCR and immunofluorescence approaches. The functional 
significance of Opsin 3 was assessed by silencing its expression in the hair follicle cells 
followed by a transcriptomic profiling. Proprietary LED-based devices emitting two discrete 
visible wavelengths were used to access the effects of selected optical parameters on hair 
growth ex vivo and outer root sheath cells in vitro. 
Results: The expression of OPN2 (Rhodopsin) and OPN3 (Panopsin, Encephalopsin) was 
detected in the distinct compartments of skin and anagen hair follicle. Treatment with 3.2 
J/cm
2
 of blue light with 453 nm central wavelength significantly prolonged anagen phase in 
hair follicles ex vivo that was correlated with sustained proliferation in the light-treated 
samples. In contrast, hair follicle treatment with 3.2 J/cm
2
 of 689 nm light (red light) did not 
significantly affect hair growth ex vivo. Silencing of OPN3 in the hair follicle outer root 
sheath cells resulted in the altered expression of genes involved in the control of proliferation 
and apoptosis, and abrogated stimulatory effects of blue light (3.2 J/cm
2
; 453 nm) on 
proliferation in the outer root sheath cells.  
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Conclusions: We provide the first evidence that 1) OPN2 and OPN3 are expressed in human 
hair follicle, and 2) 453 nm blue light at low radiant exposure exerts a positive effect on hair 
growth ex vivo, potentially via interaction with OPN3.  
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Introduction 
Photobiomodulation (PBM) has been clinically reported to have a positive impact on hair 
growth (1-3), skin rejuvenation (4,5), wound healing (6-8), psoriasis (9,10) and eczema (11). 
The lack of the risk of potential systemic side effects is well recognized as benefits in 
treatment of cutaneous disorders (12,13). Up to now the list of light-based devices for the 
management of hair regrowth with FDA 510k premarket notification clearance counts thirty 
two entries (1-3). The efficacy of light-based therapy is reported to be similar to that of 
existing FDA-approved drugs (minoxidil and ﬁnasteride) (13). However, a recent review 
highlighted the significant differences in the choice of optical parameters used by available 
devices that are still claimed to have clinically comparable hair growth-stimulating efficacy 
(14).  
From our perspective, the inconsistency in the choice of optical parameters can be addressed 
by filling the current gap in fact-based knowledge of the key molecular receptors that mediate 
the effects of light: in the field of PBM experimental-based evidence on how photons are 
received by cells is vaguely present, while the recent review discussed about at least 10 
classes of photosensor proteins and additional photosensitive domains involved in molecular 
mechanisms used by biological systems to detect light (15).  
The pioneering work of Dr Tiina Karu suggested that cytochrome c oxidase plays a role of  a 
light acceptor with absorption bands in red and near-infrared (NIR) range (650 – 980 nm) and 
even higher (about ten times) extinction coefficient in a blue-green spectral range (around 
400-500 nm) (16). It was shown that irradiation of cytochrome c oxidase using blue, red and 
near-infrared light was able to modulate not only metabolic activity, but also gene 
expression(17); however, the majority of PBM-based devices are solely relying on red and 
NIR- spectral components. 
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In recent years, several molecules have emerged as novel mediators of light activation in non-
photosensitive tissues, such as nitrosated proteins regulating nitric oxide (NO) (18-21) and the 
ﬂavoprotein-containing cryptochromes that are also involved in the regulation of the circadian 
rhythm (22). They are all absorbing in the blue part of the electromagnetic spectrum. 
Increasing evidence suggest that an additional class of light-sensitive receptors, Opsins, is 
expressed in a varieties of tissues outside the vision mediating retina (23,24). Opsins can be 
divided into two sub-families: 1) visual Opsins, including Opsin 1 (short, middle and long 
wavelength) present in cone cells and mediate colour vision,  and Opsin 2 (Rhodopsin), a 
dim-light vision mediator that is expressed in rod cells; 2) non-visual Opsins, including  
Opsin 3 (Panopsin or Encephalopsin), Opsin 4 (Melanopsin) and Opsin 5 (Neuropsin) (25). 
All these receptors are characterized by specific absorption spectra and could act as G-
protein-coupled receptors (GPCRs) mediating different signal transduction cascades (26). In 
functional Opsins, a retinal molecule binds to a highly conserved lysine residue (27). In the 
presence of light, cis retinal is isomerized to all-trans retinal, and the straightening of the 
polyene chain activates the opsin (28).  
Recent studies have revealed that the distinct members of the Opsin family are present in 
human skin and could contribute to skin homeostasis (23). For example, OPN2 expression 
was found in both human epidermal keratinocytes and melanocytes (29). A single exposure to 
violet light (380 – 410 nm) activated OPN2 and supressed keratinocyte differentiation (30). In 
human melanocytes, OPN2 was found to contribute to photo-transduction of ultraviolet A 
radiation (UVA) to increase melanin synthesis (29). OPN3 expression was found in retina, as 
well as in the cells outside of visual system, which suggest that OPN3 might function as a 
photoreceptor in various tissues (31,32). Interestingly, a homolog of the vertebrate OPN3 
maintained photosensitive properties in vitro after transfection in mammalian cells, suggesting 
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that OPN3 homologs might have same ability to bind the non-conventional isomer 13-cis 
retinal to form an active photopigment (33,34).  
It must be noted that the exact position of the absorption band in both OPN2 and OPN3 
depends on the amino-acid sequence on the type of cis retinal bound (7- 9-cis, 11-cis, 13-cis) 
(35), and also on dark versus light conditions (28). Interestingly, the respective spectral 
sensitivity of rhodopsin through animal kingdom may cover an extremely broad range of the 
sunlight spectrum from 358 nm (near ultraviolet, UVA) to 630 nm (red) (36). OPN3 was 
shown to be a bi-stable pigment absorbing in the region of 400-530 nm, generating a stable 
photoproduct and reverting to its original state upon subsequent light absorption rather than 
undergoing photobleaching (33). 
The aim of this study was to investigate the expression of selected light-sensitive receptors in 
the human hair follicle and to study the impact of blue light on hair growth ex vivo. 
 
Materials and Methods 
Human skin and hair follicle collection and culture 
Human skin was obtained from either the temporal or occipital scalp regions of female and 
male donors, and from the beard region of male donors undergoing elective cosmetic surgery 
(total n=12, age 32-70). Tissue was obtained with full written consent adhering to the 
Declaration of Helsinki principles, following ethical and institutional approval under human 
tissue act guidelines.  
RNA extraction and RT-PCR analysis   
Microdissected HFs were collected in 1 ml of TRIzol® (Life technologies), mechanically 
homogenized and stored at -80°C. RNA isolation was performed using Direct-zol™ RNA 
MiniPrep kit (Zymo research). cDNA was synthesised by reverse transcription using the 
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High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems™). PCR reactions 
were performed with primers corresponding to the retinal-binding site of human Opsins 1, 3, 
4 and 5 (Table 1) touchdown PCR protocol as previously published (24). For amplification of 
OPN2 (Table 1) standard PCR conditions were employed: 95°C for 2 min, followed by 34 
cycles of denaturation (95°C for 20 s), annealing (51°C for 20 s), and elongation (72°C for 30 
s). 
Quantitative RT-PCR was performed with SYBR Green Supermix (Applied Biosystems), 
using 10 ng cDNA and 1 μM primers (Table 2), and StepOnePlusTM real-time PCR system 
(Applied Biosystems). Differences between samples were calculated using the Genex
TM 
software (Bio-Rad) based on the Ct (Ct
∆∆
) equitation method and normalized to the 
housekeeping GAPDH gene. Total RNA from the human eye (Amsbio) and from HaCaT cell 
lines was used as the positive control. 
 
Immunofluorescence 
Six-µm cryosections were briefly air-dried followed by fixation in acetone (10 min, 20°C) or 
in 4% PFA (10 min, room temperature). The cryosections were incubated with 5% BSA for 1 
hour at room temperature (Sigma) followed by application of optimal dilutions of primary 
antibodies over-night at 4°C (Table 3). Subsequently, sections were incubated with 
corresponding secondary antibodies, Alexa 488 or Alexa 647 (Invitrogen) for 1 hour at 37
°
C. 
Incubation steps were interspersed by four washes with phosphate buffer-saline (PBS 1x, 5 
min each). Cell nuclei were counterstained using VECTASHIELD® mounting medium 
containing DAPI (Vector Labs). Image analysis was performed using a ﬂuorescent 
microscope in combination with DS-C1 digital camera and ACT-2U image analysis software 
(Nikon).  
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Hair follicle stem cell sorting 
Hair follicle stem cells were obtained from the scalp skin of 3 female donors (44-, 66 - and 
70-years-old) as published before (37). Briefly, microdissected skin was incubated with 
Dispase I (Roche) overnight at 4°C followed by the separation of epidermis and the HFs from 
the dermis using forceps. At least 50 HFs were treated with 0.05% trypsin- 0.02% EDTA at 
37°C for 30 min. Enzymatic digestion was neutralized by 10% FBS in PBS. Cells were 
filtered through a 40 um nylon mesh filter, pelleted by centrifuging at 170 g for 5 minutes and 
re-suspended in PBS with 0.5% BSA. Cells were stained with a mix of anti-human PE-
conjugated CD200 (eBioscience), APC-CD34 (eBioscience) and FITC-CD49f integrin 
(eBioscience) antibodies for 30 min at 4°C followed by 15 minutes incubation  with 7-AAD 
(BD Pharmingen) on ice to identify living cells. Two stem cell populations, CD200+/CD49f+ 
and CD34+/CD49f+, were sorted using Moflo XDP cell sorter (Beckman Coulter), and 
collected in TRIzol® LS Reagent (Life technologies) for total RNA isolation. 
 
Cell culture and transfection  
Primary human outer root sheath (ORS) keratinocytes were isolated from anagen HFs as 
described previously (37) and cultured in Keratinocyte Growth Medium 2 supplemented with 
Bovine Pituitary Extract 0.004 ml / ml, Epidermal Growth Factor (recombinant human) 0.125 
ng/ml, Insulin (recombinant human) 5 μg/ml, Hydrocortisone 0.33 μg/ml, Epinephrine 0.39 
μg/ml, Transferrin-holo (human) 10 μg/ml, and CaCl2 0.06 mM (Promocell) for no more than 
3 passages. For OPN3 knockdown, ORS cells were transfected with 50 nM of smartpool 
siRNAs directed against OPN3 (ON-Targetplus) and a non-targeting control (Dharmacon) 
using Lipofectamine (RNAiMax, Invitrogen) according to the manufacturers’ protocol.  
 
Microarray and bioinformatic analysis  
Total RNA was extracted from the ORS cells 48 hours post OPN3 siRNA transfection as 
described above. RNA was tested by capillary electrophoresis on an Agilent 2100 bioanalyzer 
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(Agilent) and high quality was confirmed. Gene expression profiling was performed using 
arrays of human HTA-2_0-st-type from Affymetrix. Biotinylated antisense cRNA was then 
prepared according to the Affymetrix standard labelling protocol with the GeneChip® WT 
Plus Reagent Kit and the  GeneChip® Hybridization, Wash and Stain Kit (both from 
Affymetrix, Santa Clara, USA). Afterwards, the hybridization on the chip was performed on a 
GeneChip Hybridization oven 640, then dyed in the GeneChip Fluidics Station 450 and 
thereafter scanned with a GeneChip Scanner 3000. All of the equipment used was from the 
Affymetrix-Company (Affymetrix, High Wycombe, UK). A Custom CDF Version 20 with 
ENTREZ based gene definitions was used to annotate the arrays (38). The Raw fluorescence 
intensity values were normalized applying quantile normalization and RMA background 
correction. ANOVA was performed to identify differential expressed genes using a 
commercial software package SAS JMP10 Genomics, version 6, from SAS (SAS Institute, 
Cary, NC, USA). A false positive rate of a=0.05 with FDR correction was taken as the level 
of significance.  
 
Light treatment 
Microdissected  HFs from 7 donors (53-55 year old) were cultured in phenol red-free 
Williams E medium (Life Technology) supplemented with hydrocortisone 10 ng/ml (Sigma-
Aldrich), L-glutamine 2 mM (Sigma-Aldrich), and Penicillin 1000 U/ml / Streptomycin 
1mg/ml, with or without 10 µg/ml insulin (Sigma-Aldrich) (39). Williams E medium contains 
traces of retinol. Since HF cells are known to possess a system for synthesis and metabolism 
of retinoids (62), no cis-retinal was added to the culture medium. HFs were cultured at 37°C 
in a humidified atmosphere of 5% CO2 up to 14 days. Light treatment was performed using 
two proprietary LED-based devices with flat homogeneous illumination over the area of 24-
well plates. Each device was emitting one discrete wavelength: 453 nm central wavelength, 
16 nm full width half maximum (PHILIPS, The Netherlands) previously used for the 
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experiments on in vitro human cells study and in human clinical trials (18,40), and 689 nm 
central wavelength, 24 nm full width half maximum (PHILIPS, The Netherlands). Separate 
groups of HFs were treated daily using 453 nm or 689 nm wavelengths, 16mW/cm
2 
irradiance, 3.2 J/cm
2
 radiant exposures during 10 consecutive days.
 
Optical power was 
measured before each experiment using Nova II power meter (Ophir Optronics Solutions Ltd) 
at the plane of HFs, assuring delivery of the correct irradiance (watts per area). No increase in 
temperature above 37°C was observed as monitored using FLIR A655sc Infrared Camera, 
(FLIR® Systems, Inc). Culture medium was refreshed every other day over the period of light 
treatment following the protocol of Mignon et al (41). The images were taken with wide-field 
microscope (Leica) for morphological evaluation.  
 
Alamar Blue® metabolic activity assay 
Primary ORS keratinocytes were seeded into 24 well-plate with a black frame (Porvair) at a 
density of 60000 cells per well, and cultured in fully supplemented phenol red free 
Keratinocyte Growth Medium 2 (Promocell). The cell mono-layers were treated with 3.2 
J/cm
2
 light (453 nm) using a proprietary LED-based device as described above. The changes 
in metabolic activity were assessed 24 hours after irradiation, using the Alamar Blue® assay 
(Thermofisher) following the manufacturer protocol. The fluorescence intensity of the 
supernatant was measured using a temperature controlled plate reader (FLUOstar OPTIMA, 
BMG Labtech).  
 
EdU incorporation assay 
ORS cells were grown on coverslips coated with 0.5% gelatin and treated with 3.2 J/cm
2
 light 
(453 nm) as described above (n=4). To investigate if OPN3 is involved in mediating the 
effects of blue light cells were transfected with either scrambled siRNA (control) or siRNA 
against OPN3 after their exposure to 3.2 J/cm2 light (453 nm) as described above.  After the 
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light treatment cells were incubated with fresh media containing 10 uM of the thymidine 
analogue EdU that incorporates into newly synthesized DNA (Click-iT® EdU Imaging Kits, 
Invitrogen). The cells were fixed in 4% PFA (10 minutes, room temperature). EdU detection 
was assessed following the manufacturer protocol. Cell nuclei were counterstained using 
VECTASHIELD® mounting medium containing DAPI (Vector Labs). Image acquisition was 
performed using a ﬂuorescent microscope in combination with DS-C1 digital camera and 
ACT-2U image analysis software (Nikon). The percentage of proliferating cells was 
calculated from the total number of cells. Image J software was employed for image analysis.    
 
 
Statistical analysis 
For the analysis of HF growth ex vivo, the effects of medium, donor, and light treatments on 
mean survival time with standard errors, were based on a random-effects interval-data 
regression model. A commercial software package was used: StataCorp. 2015. Stata 
Statistical Software: Release 14. College Station, TX: StataCorp LP. T-test and Two-way 
ANOVA was performed using GraphPad Prism version 6.04 for Windows, GraphPad 
Software, La Jolla California USA, www.graphpad.com. 
 
Results 
Light-sensitive receptors, Opsin 2 and Opsin 3 are expressed in the human hair follicle  
To investigate the expression of putative molecular targets for light therapy in human anagen 
HFs, a screening of Opsin receptor transcripts was performed by RT-PCR. Primers 
encompassing the Lysin residue that is required for the photo-activation of Opsin receptors 
were employed for OPN1SW, OPN1MW, OPN2 (Rhodopsin), OPN3 (Panopsin or 
Encephalopsin), OPN4 (Melanopsin), and OPN5 (Neuropsin) (24). RNA isolated from human 
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retina was used as a positive control. Only specific PCR products corresponding to OPN2 and 
OPN3 were detected in the HFs, whilst the expression of other Opsins was not observed 
(Figure 1A). To compare the relative levels of Opsins in anagen HF, RT-qPCR analysis was 
performed that revealed the higher OPN2 expression compared to OPN3 in 5 out of 6 samples 
analysed; such expression pattern was sex and age independent (Figure 1B).  
Immuno-fluorescence analysis was performed to characterize the localization of detected 
light-sensitive receptors in skin. Prominent expression of OPN2 was seen in the epidermis and 
in dermal fibroblasts in skin obtained from either male beard or female scalp regions (Figure 
2A, B, respectively). OPN2 expression was co-localized with cytokeratin 14 (CK14), 
suggesting the presence of OPN2 in the basal epidermal layer (Figure 2B). In the HF, the 
expression of OPN2 was restricted to the lower and upper ORS (Figure 2C). Similar pattern 
of OPN2 expression was detected in terminal (Figure 2D) and vellus HFs (Figure 2E). In 
addition, OPN2 expression was seen in the HF compartment harbouring the stem cells (bulge) 
as demonstrated by the double staining of OPN2 with a stem cell marker CD200 (Figure 2F-
G).  
Analysis of OPN3 expression revealed its presence in the epidermal layers, as well as in the 
dermis (Figure 3A). In the HFs, OPN3 expression was predominantly seen in the inner root 
sheath (IRS). Similar pattern of OPN3 expression was seen in the terminal HFs derived from 
the scalp (Figure 3B) and vellus HFs (Figure 3C). IRS specific OPN3 expression was further 
confirmed by double-immunolabelling with AE15 that detects trichohyalin, an intermediate 
filament-associated protein involved in the IRS differentiation (Figure 3D). Expression of 
OPN3 was not detected in the hair cortex as it was confirmed by a double-immunostaining 
with a marker AE13 (Figure 3E). 
In addition, the expression of OPN2 and OPN3 was investigated in the follicular stem cells 
(HFSC) isolated from anagen HFs, using a combination of antibodies against CD200, CD34 
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and CD49f-integrin markers, as described previously (42) (Figure 4A). CD200 is a cell-
surface marker of the epithelial HFSC found in the bulge region, while CD34 is expressed in 
the HFSC of the suprabulbar ORS (42-45). By qPCR, OPN2 and OPN3 transcripts were 
detected in both CD200+ and CD34+ cell populations from 3 female donors of different age 
(43, 66 and 70-y-o) (Figure 4B).  
Because expression of OPN3 was detected in the keratinocytes of the IRS that do not undergo 
proliferation, the effect of OPN3 silencing was evaluated in highly proliferative cultured ORS 
cells. RT-PCR analysis confirmed expression of OPN3 transcripts in these cells (Figure 5A). 
Silencing of OPN3 did not cause any gross changes on cell morphology (Figure 5 B). 
Efficiency of OPN3 silencing was confirmed by real-time PCR analysis: over 80% decline in 
OPN3 transcript level was observed in siRNA - OPN3 treated cells comparing to the control 
(Figure 5 C). Microarray analysis of the global gene expression in the ORS keratinocytes 
treated with OPN3 siRNA or corresponding control revealed the altered expression of 41 
genes (Table 4): 37 were downregulated, while only 4 were upregulated due to OPN3 
knockdown. Microarray validation by qPCR confirmed that the expression of UL16 binding 
protein 1 (ULBP1), p21 protein (Cdc42/Rac)-activated kinase (PAK2), follistatin-like 1 
(FSTL1) and ubiquitin protein ligase E3 component N-recognin 5 (UBR5) was downregulated 
in the ORS cells after OPN3 silencing (Figure 5E). In contrast, the expression of sideroflexin 
1 (SFNX1), caveolin 2 (CAV2) and biogenesis of lysosomal organelles complex 1 subunit 2 
(BLOC1S2) was increased due to OPN3 silencing in the ORS cells (Figure 5E). 
Taken together, our data assert that light-sensitive receptors OPN2 and OPN3 are expressed in 
the epidermal and HF keratinocytes, including HFSC; their specific localization might suggest 
their implication in epidermal and HF homeostasis.      
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Blue light prolongs anagen hair growth phase ex vivo 
Blue light could interact with a variety of photoactive proteins: NADPH oxidase, nitrozated 
proteins (18,20), light-activated enzyme, cytochrome c oxidase (46) , intracellular calcium 
and light-gated ion channels (47), and circadian photoreceptors cryptochromes 1 and 2 (48).  
This could further activate secondary messengers, like nitric oxide and other ROS, cAMP, 
ATP and Ca2+ (14). Such a versatile range of photochemical reactions has a potential to 
trigger photobiological effects underlying the therapeutic action of PBM (49). 
As both Opsins 2 and 3 have also absorption bands in the blue-to-green region (33,34) we 
tested the impact of 453 nm wavelength light on hair growth by performing daily irradiation 
of HFs ex vivo during 10 consecutive days. 
Recently we have demonstrated stimulatory effect of low radiant exposure, 2 J/cm
2
 of blue 
450 nm light on reticular and papillary dermal fibroblasts (41). Therefore, irradiance and 
radiant exposure were set to low levels (16 mW/cm
2
 irradiance, 200 sec illumination duration, 
3.2 J/cm
2 
radiant exposure) to assure initiation of purely photobiological effects and to avoid 
any photothermal reactions.  
We have also evaluated the impact of low levels of red light (689 nm, 16 mW/cm
2
 and 3.2 
J/cm
2
). While this frequency most probably lies outside of the absorption band of discovered 
Opsins, we included it in our experiments as red wavelength at low radiant exposure is most 
often used in in vitro and animal experiments and in the devices for in vivo hair growth (1,3). 
It also falls within the absorption spectrum of cytochrome c oxidase, a chromophore that is 
often attributed to be responsible for PBM-mediated effects (50-52). 
HFs were divided into different groups: a control group was kept in the dark, while treated 
groups were exposed daily to either red or blue light during 10 days. Culture medium was 
refreshed every other day after light irradiation. HF gross morphology was monitored daily 
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using a wide-field microscope to distinguish anagen and catagen phases (Figure 6A). An 
interval regression with random intercept model was applied to analyse anagen to catagen 
transition, where mean survival time of a HF in culture (anagen maintenance) was selected as 
a measure. Effects of medium, donor and light treatments on mean survival time from 7 
independent experiments are shown in Figure 6 B. HF growth in the media without insulin 
was used as a positive control for this study. Insulin depletion caused significant premature 
catagen development (p=0) that is consistent with previously published data (53). A donor 
effect was also statistically significant (p=0.012).  This has confirmed the applicability and 
quality of the statistical model. A radiant exposure of 3.2 J/cm
2
 of blue light has increased 
mean survival time of HF ex vivo, improving anagen maintenance (pairwise comparison 
control versus blue light significant at 10% level, p=0.066) (Figure 6 B). In contrast, HF 
treatment with 3.2 J/cm
2
 of 689 nm light (red light) did not significantly affect hair growth 
compared to the untreated control (pairwise comparison control versus red light, p=0.7) 
(Figure 6 B). Positive effects of blue light on hair growth was further confirmed by the 
assessment of proliferation in HFs: the number of proliferative Ki-67+ cells was significantly 
increased at day 2 post treatment with low level of blue light compared to the control (p=0.04) 
(Figure 6 C).  
In addition, low level of blue light (3.2 J/cm
2
,
 
450 nm), stimulated metabolic activity of the 
ORS keratinocytes in vitro, as it was determined by the Alamar assay (p=0.05) (Figure 6 D) 
and significantly (p=0.004) increased proliferation compared to the control cells (Figure 6 E). 
Interestingly, silencing of OPN3 abrogated stimulatory effects of blue light (3.2 J/cm
2
, 453 
nm) on proliferation in the ORS cells (Figure 6 F). Significant inhibition (p<0.0001) in 
proliferation rate was observed in the ORS cells treated with blue light and transfected with 
OPN3 siRNA compared to the cells treated with blue light and transfected with control 
(scrambled) siRNA (Figure 6 F). 
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Discussion 
Over the last decades, PBM has been suggested as an approach for hair loss treatment 
alternative to drugs. Several clinical studies reported encouraging results demonstrating the 
increase in hair density and thickness in response to red and near infrared light-based therapy 
(54). However, the exact molecular mechanism underlying light-mediated hair regrowth 
remain largely unknown (2,55). 
The effect of PBM is triggered by the interaction of low levels of light with endogenous 
chromophores and photoreceptors in the skin (14,56). There is a rich spectrum of molecules 
absorbing optical radiation over the whole visible and near-infrared range (14,56). 
The effects of blue light could be mediated by photolytic generation of NO from nitrozated 
proteins (18,20), ROS formation as a result of enzymatic reactions of e.g. NADPH oxidase 
(57), and cytochrome c oxydase (46). Alternatively, it could be mediated by photoactive 
pigments or chromophores (including the flavins and retinal) bound to cryptochromes 1 and 2 
(48), intracellular calcium and light-gated ion channels (47), and opsin family proteins 
(29,30).  Light interaction with all these potential molecular targets could lead to multiple 
downstream reactions, such as changes in pH, [Ca2+], cAMP, ATP, NO) (14,47).  
Despite of such a long list of potential absorbers of blue light, the shorter-wavelength UV-free 
part of the electromagnetic spectrum remains to be relatively unexplored.  The latter could 
possibly be explained by a relatively short penetration depth of this part of the 
electromagnetic spectrum. However, 450 nm light is successfully used for treatment of 
cutaneous diseases, including psoriasis and eczema (10,11), suggesting sufficient blue light 
penetration into the skin. Additional optical beam manipulations (58) might allow the photons 
of blue light at sufficient density to reach HF epithelial cells, including the bulge stem cells 
located in the outer root sheath. 
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In this study, we showed for the first time that OPN2 and OPN3, the photoreceptors absorbing 
light in visible blue-green wavelength range, are expressed in human skin, epithelial and 
mesenchymal components, and in the distinct compartments of the anagen HFs. Our data are 
in consistence with the study of Denda et al who demonstrated the expression of OPN2 in the 
human epidermal keratinocytes (23). In addition, we observed specific OPN2 expression in 
the basal layer keratinocytes expressing Keratin 14 (Figure 2 B). Intriguingly, the expression 
of both OPN2 and OPN3 was detected in the HF stem cells (Figure 4).  
These findings suggest that the activity of HF stem cells might be modulated by blue-green 
visible light within the absorption band of discovered Opsins directly interacting with them 
and activating GPCR-related pathways or via more complex reaction cascades, involving 
additional chromophores or photoreceptors, for example, cytochrome c oxidase, nitrosated 
proteins, cryptochromes, and others. Interestingly, transcriptomic analysis revealed that 
silencing of OPN3 expression in the proliferating ORS keratinocytes leads to the altered 
expression of genes involved in the control of stem cell activity in skin and hair follicle 
(Figure 5). For example, the expression of p21-activated kinase 2 (PAK2) and follistatin-
like1 (FSTL1) was downregulated due to OPN3 silencing. PAK2 plays a role in a variety of 
different signaling pathways including cytoskeleton regulation, cell motility, apoptosis or 
proliferation. PAK2 acts as a downstream effector of RAC1 that leads to the inhibition of c-
Myc (59,60). Both RAC1 and c-Myc are implicated in the control of epidermal stem cell (61). 
FSTL1 inhibits bone morphogenetic protein (BMP) suppressive effects in telogen HF stem 
cells allowing the initiation of the new hair cycle (62). Furthermore, in vitro analysis of the 
effect of OPN3 downregulation on cell proliferation revealed the significant decrease in the 
number of proliferative EdU positive cells compared to the corresponding controls (Figure 6 
F), highlighting a novel previously unrecognised role for OPN3 in cell cycle modulation in 
the HF cells. 
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Photosensitivity of visual Opsins requires biding of the 11-cis-retinal chromophore to a Lysin 
residue of the G protein coupled receptors; while 11-cis retinal is abundantly present in the 
eye to ensure the formation of a functional receptor, all-trans retinals are mostly present in 
non-photosensitive tissues (33,63). Nevertheless, it has been reported that homologs of 
vertebrate OPN3 in pufferfish and mosquito becomes light sensitive when it is bound to 13-
cis-retinal, and it might function as photoreceptors in many tissues (63). Therefore, the 
expression of OPN2 and OPN3 in the different HF compartments stimulated our interest in 
understanding the physiological role for Opsins in hair growth and their possible involvement 
in light sensing capability of the HF.   
It has been demonstrated that keratinocyte irradiation with blue light of 412-426 nm at 
relatively high radiant exposure causes toxic effects (18). In addition, 41.4 J/cm2 453 nm blue 
light irradiation rapidly induces ROS production and anti-proliferative effects (18,64).  
In our study, we observed that low level of light at 453 nm wavelength (which falls within 
Opsins absorption spectrum) perpetuate anagen phase in HF ex vivo associated with sustained 
proliferation in the hair matrix keratinocytes that was diminished in the untreated control 
(Figure 6). Interestingly, low radiant exposure of 3.2 J/cm
2
 stimulated metabolic activity in 
the ORS cells and promoted their proliferation (Figure 6). A positive effect of low levels of 
453 nm blue light has recently been demonstrated in the dermal fibroblasts: the activation of 
metabolic activity and even more, the increased collagen production by papillary fibroblasts 
(41), and increased total protein synthesis (65). Therefore, these reports suggest that low 
levels of blue light could promote positive effects on cell growth and functions. In line with it, 
our study demonstrated that 3.2 J/cm
2
 of blue light with 453 nm central wavelength exert 
beneficial effect on anagen maintenance of HF ex vivo. Interestingly, the stimulatory effect of 
blue light on proliferation was negated by silencing of OPN3: downregulation of OPN3 in 
vitro dramatically reduced proliferation rate, which was induced by blue light treatment in 
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primary ORS cells (Figure 6). These findings support our hypothesis that positive effects of 
blue light on hair growth could be mediated, at least in part, by light-sensitive receptors such 
as OPN3.  
Despite numerous existing publications about responsiveness of HFs and HF cells to red light 
and existing commercial red light-emitting devices for hair growth stimulation, in our study 
3.2 J/cm
2
 of 689 nm light (red light) did not significantly affect hair growth ex vivo (p=0.7). 
However, this lack of statistical significance does not necessarily serve as evidence of the 
absence of positive effect of red light. We have recently published Viewpoint review (14) that 
summarizes the investigation of 90 reports published between 1985 and 2015, mostly based 
on application of red and near-infrared light. This investigation identified major 
inconsistencies in optical parameters between the published studies: a variety of the optical 
ranges of photon density applied in in vitro and ex vivo settings has been shown to extent over 
two orders of magnitude. Strikingly, same or very similar optical parameters used in different 
studies have been reported to trigger diverse effects on the cell (18,66-68); in addition, culture 
conditions can also have a huge impact on the outcome of the experiment (41). Therefore, we 
would like to emphasize the importance of careful experimental design in combination with 
well-characterized optical devices and biological models. 
 
Conclusion 
We provide the first evidence that OPN2 and OPN3 are expressed in human HF, and that 453 
nm blue light at low radiant exposure exerts a positive effect on hair growth ex vivo, 
potentially via interaction with OPN3. The further research should be conducted to decipher 
interactions between blue light and Opsin receptors in the HFs, as well as to investigate a role 
of other blue-light acceptors in the control of hair growth. In addition, the beneficial effect of 
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blue light at low radiant exposure on hair growth raises a possibility of increasing therapeutic 
efficacy when combined with topical chemistry used for management of hair growth.  
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List of Abbreviations 
7-AAD, 7-aminoactinomycin D  
AE 13, Hair cortex cytokeratin  
AE 15, Trichohyalin 
APC, Allophycocyanin 
BLOC1S2, Biogenesis of lysosomal organelles complex 1 subunit 2 
BMP, Bone morphogenetic protein 
BSA, Bovine serum albumin 
CAV2, Caveolin 2 
CD200, OX-2 membrane glycoprotein 
CD34, Hematopoietic progenitor cell antigen CD34 
CD49f integrin, Integrin alpha 6 
cDNA, Complementary deoxyribonucleic acid 
CK 14, Cytokeratin 14 
DAPI , 4',6-diamidino-2-phenylindole 
EDTA, Ethylenediaminetetraacetic acid  
EdU, 5-ethynyl-2′-deoxyuridine 
FBS, Fetal bovine serum 
FDA, Food and Drug Administration 
FDR, False discovery rate 
FITC, Fluorescein isothiocyanate 
FSTL1, Follistatin-like 1 
GAPDH, Glyceraldehyde 3-phosphate dehydrogenase 
GPCR, G-protein-coupled receptors 
HaCaT, Immortalized cultured human keratinocytes cell line 
HF, Hair follicle 
HFSC, Hair follicle stem cells 
IRS, Inner root sheath 
LED, Light-emitting diode 
NIR, Near-infrared 
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NO, Nitric oxide 
OPN1sw, Opsin 1 short wavelength 
OPN1sw, Opsin 1 middle wavelength 
OPN2, Opsin 2, Rhodopsin 
OPN3, Opsin 3, Encephalopsin  
OPN4, Opsin 4, Melanopsin 
OPN5, Opsin 5, Neuropsin 
ORS, Outer root sheath  
PAK2, p21 protein (Cdc42/Rac)-activated kinase 
PBM, Photobiomodulation 
PBS, Phosphate-buffered saline 
PCR, Polymerase chain reaction 
PE, Phycoerythrin  
PFA, Paraformaldehyde  
qPCR, Quantitative polymerase chain reaction 
RNA, Ribonucleic acid 
ROS, Reactive oxygen species 
RT-PCR, Reverse transcription polymerase chain reaction 
RT-qPCR, Reverse transcription-quantitative Polymerase chain reaction 
SFNX1, Sideroflexin 1 
siRNA, Small interfering RNA 
siSc, siRNA scrambled (negative RNA control) 
siOPN3, siRNA against OPN3 
UBR5, Ubiquitin protein ligase E3 component N-recognin 5 
ULBP1, UL16 binding protein 1 
UVA, Ultraviolet A 
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Figure Legends 
Figure 1: Expression of Opsins in human hair follicle. (A) RT-PCR: only OPN2 and OPN3 
were amplified from HFs cDNA, whilst Opsin1 short and middle wavelength (OPN1sw and 
OPN1mw), OPN4 and OPN5 amplicons were not detected. Human retina (R) or HaCaT cell 
line cDNA were used as positive controls. (B) RT-qPCR: relative expression of OPN2 and 
OPN3 were measured in anagen micro-dissected HFs from 6 patients of different gender and 
age. OPN2 transcript levels are expressed at the higher level than OPN3 in 5 out of 6 patients. 
Sex and age of each donor are below bar clusters (mean ±SD; n=2). Abbreviations: M – male; 
F – female 
Figure 2: Localisation of OPN2 (Rhodopsin) in human skin. Immunofluorescence: (A) 
OPN2 (red) is expressed in the epidermis and dermal fibroblasts (arrows). (B) OPN2 (red) 
expression in the basal layer of epidermis, which is co-localised with CK14 (green, arrow-
heads). (C) Expression of OPN2 (red) in anagen HFs along the ORS. (D-E) OPN2 (red) 
expression in the lower outer root sheath in terminal (D, arrows) and vellus (E, asterisk) HFs. 
(F-G) Co-expression of OPN2 (red) with CD200 (green), a marker of stem cells in human 
HFs. Scale bar 50 µm. Nuclear staining: DAPI (blue). Abbreviations: DP - dermal papilla; 
ORS - outer root sheath. 
Figure 3: Localisation of OPN3 in human skin: (A) OPN3 (green) is expressed in the 
epidermis and in the dermal fibroblast (arrows); OPN3 (green) is expressed in the inner root 
sheath of terminal anagen HFs of female scalp (B) and vellus HF in male facial skin (C). (D-
E) Double immunostaining of OPN3 (green) with either trichohyalin (AE15, red) or hair 
cortex cytokeratin (AE13, red): OPN3 is co-localized with AE15, but not with AE13. Scale 
bar 50 µm. Nuclear staining: DAPI (blue). Abbreviations: DP - dermal papilla; IRS - inner 
root sheath 
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Figure 4: mRNA expression of OPN2 and OPN3 is detected in the hair follicle stem cells. 
HFSC were sorted from total skin (n=3; 43-70-y-o). (A) Representative dot-plots showing 2 
populations of HFSC: CD200+/CD49f+ cells and CD34+/CD200. (B) RT-qPCR: OPN2 and 
OPN3 expression was detected in both CD200+ and CD34+ enriched stem cell populations 
obtained from three donors. (mean ±SD; n=3). Abbreviation: F – female 
Figure 5: Effects of OPN3 on the outer root sheath (ORS) cells in vitro. (A) RT-PCR: 
OPN2 and OPN3 transcripts were detected in the ORS keratinocytes in vitro. (B) No 
morphological changes were observed in the ORS cells after 48 h of OPN3 silencing 
(siOPN3). (C) RT-qPCR: dramatic decrease in OPN3 expression (83%) in the ORS cells due 
to OPN3 siRNA transfection (mean ±SD; n=3). (D) Microarray validations by RT-qPCR: 
knock-down of OPN3 induced downregulation of ULBP1, PAK 2, FSTL1, UBR5 and 
upregulation of BLOC1S2, CAV2, SFXN1 expression (mean ±SD; n=3). 
Figure 6: Effects of 3.2 J/cm
2
 of blue light with 453 nm central wavelength on hair 
follicle growth ex vivo. (A) Representative microphotographs of anagen and catagen HFs at 
day 0 and day 7 of the experiment. (B) Effects of medium conditions (with insulin versus no 
insulin), donors and light treatment (blue and red light) on anagen to catagen transition 
expressed as mean survival time with 95% confidence intervals: insulin depletion caused 
premature catagen development as expected; donor effect was statistically significant 
(p=0.012), low levels of blue light increased mean survival time, improving anagen 
maintenance (pairwise comparison control vs blue light, significant at 10% level, p=0.066, 
mean ±SE); red light effect was not statistically significant (p=0.7). (C) Immunofluorescence: 
detection of proliferative Ki-67+ cells (green) in the hair matrix. Scale bar 50 µm. Nuclear 
staining: DAPI (blue); quantitative analysis revealed the statistically increased number of Ki-
67+ cells in the HF treated with blue light (mean ±SD; p=0.04, Student’s t-test); (D) Alamar 
assay: increase in metabolic activity in the ORS keratinocytes in vitro after 3.2 J/cm
2
 of blue 
35 
 
light (n=3; mean + SD, p<0.05, Student’s t-test). (E) EdU assay: the number of proliferating 
ORS cells is significantly increased 8 hours after blue light irradiation (n=4; mean + SD, 
p=0.004, Student’s t-test). (F)  Silencing of OPN3 in the ORS cells by siRNA significantly 
decreases proliferation rate compared to the control (scrambled) RNA and significantly 
represses proliferation induced by 3.2 J/cm
2
 blue light (p<0,0001, two-way ANOVA test). 
Abbreviations: siSc - siRNA scrambled (negative RNA control); siOPN3 - siRNA against 
OPN3 
 






